Prevalence and resistance spectrum of ahpC mutations in isoniazid-resistant Mycobacterium tuberculosis isolates
Microbiology Spectrum · 07.04.2026 · 14 (4)
DOI: 10.1128/spectrum.02496-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 07.04.2026. Verfasst von Xiaomeng Wu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Respiratory Diseases, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, Beijing Key Labora…. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Isoniazid, Antitubercular Agents, Bacterial Proteins. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
To characterize the mutation profile of the ahpC gene in isoniazid resistance (INH r ) Mycobacterium tuberculosis (MTB) isolates and to evaluate the correlation between specific mutations and resistance levels, a total of 1,337 INH r MTB isolates were collected through the Chinese Drug Resistance Surveillance Program (2013–2020). The minimum inhibitory concentrations (MICs) for INH, rifampicin (RIF), and ethionamide were determined by broth microdilution, followed by whole-genome sequencing analysis. Among 1,337 INH r - MTB isolates, 45.5% (608/1,337) were multidrug-resistant (MDR), and 54.5% (729/1,337) were RIF-sensitive cases, with lineage 2 predominating (1,013/1,337, 75.8%). Resistance mutations were identified in 79.1% (1,058/1,337) of strains, primarily katG Ser315Thr (65.5%, 695/1,058) and inhA C-777T (19.7%, 208/1,058). Notably, 5.3% (56/1,058) isolates harbored standalone ahpC mutations, with 83.3% (5/6) C-81T, 60.0% (9/15) G-48A, 57.1% (4/7) C-54T, 50.0% (3/6) C-57T, and 42.1% (8/19) C-52T mutations showing high-level INH resistance. Accordingly, 91.7% (11/12) dual katG 315 + inhA mutations conferred high-level INH resistance, while ahpC C-57T mutants universally exhibited MDR. The ahpC mutations are associated with high-level INH resistance in variants without concurrent katG or inhA mutations. This finding significantly advances our understanding of tuberculosis resistance profiling, enabling more comprehensive detection of INH r -MTB and optimizing therapeutic strategies. IMPORTANCE Among INH-resistant MTB clinical isolates, mutations in the ahpC promoter region have been considered to occur in combination with other mutations, such as katG and inhA , in a compensatory role. While the ahpC mutations have been incorporated into the World Health Organization (WHO)-recommended rapid diagnostic test, Xpert MTB/extensively drug-resistant tuberculosis (XDR), it has been still ambiguous about the standalone effects on INH resistance spectrum. Our findings demonstrate that the ahpC mutations are associated with high-level INH resistance in variants without concurrent katG or inhA mutations. This finding significantly advances our understanding of TB resistance profiling, enabling a more comprehensive detection of INH r -MTB and optimizing therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Respiratory Diseases, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, Beijing Key Laboratory of Core Technologies for the Prevention and Treatment of Emerging…
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Center for Tuberculosis Control and Prevention, Chinese Centre for Disease Control and Prevention, Beijing, China.
- Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Medical School, University of Chinese Academy of Sciences, Beijing, China.
ORCID-Profile: Xichao Ou, Yanlin Zhao, Lin Sun
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wu, X., Zheng, H., Chen, Y., Zhao, B., Li, F., Xia, H., Xiao, J., Qi, H., Jiao, W., Mi, K., Ou, X., Zhao, Y., & Sun, L. (2026). Prevalence and resistance spectrum of ahpC mutations in isoniazid-resistant Mycobacterium tuberculosis isolates. Microbiology Spectrum, 14(4). https://doi.org/10.1128/spectrum.02496-25
Vancouver
Wu X, Zheng H, Chen Y, Zhao B, Li F, Xia H, et al. Prevalence and resistance spectrum of ahpC mutations in isoniazid-resistant Mycobacterium tuberculosis isolates. Microbiology Spectrum. 2026;14(4). doi:10.1128/spectrum.02496-25
BibTeX
@article{Wu2026,
author = {Wu, Xiaomeng and Zheng, Huiwen and Chen, Yiyi and Zhao, Bing and Li, Feina and Xia, Hui and Xiao, Jing and Qi, Hui and Jiao, Weiwei and Mi, Kaixia and Ou, Xichao and Zhao, Yanlin and Sun, Lin},
title = {Prevalence and resistance spectrum of ahpC mutations in isoniazid-resistant Mycobacterium tuberculosis isolates},
journal = {Microbiology Spectrum},
year = {2026},
volume = {14},
number = {4},
doi = {10.1128/spectrum.02496-25}
}
EUVIMED